SCHEMBL3273530

SCHEMBL3273530

CC(C)(C)OC(=O)N1CCN(c2cc(-c3ccccc3)ncn2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.62
SKP1 P63208 2/20 0.62
SKP2 Q13309 2/20 0.62
HRH4 Q9H3N8 1/20 0.60
KIT P10721 2/20 0.59
NPC1 O15118 1/20 0.55
TSHR P16473 1/20 0.55
RECQL P46063 1/20 0.55
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MAP4K4 O95819 1/20 0.52
GPR119 Q8TDV5 5/20 0.51
SMARCA2 P51531 1/20 0.51
SMARCA4 P51532 1/20 0.51
PBRM1 Q86U86 1/20 0.51
ABCB1 P08183 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.50
ITGB2 P05107 1/20 0.49
ICAM1 P05362 1/20 0.49
ITGAL P20701 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3270107 0.89 MAP4K4 (0.50) CKS1BSKP1SKP2HRH4KIT
SCHEMBL3269829 0.88 CKS1B (0.52) CKS1BSKP1SKP2HRH4KIT
SCHEMBL30718193 0.85 CKS1B (0.54) CKS1BSKP1SKP2HRH4KIT
SCHEMBL27029576 0.85 CKS1B (0.54) CKS1BSKP1SKP2HRH4KIT
SCHEMBL3268033 0.84 SMARCA2 (0.53) CKS1BSKP1SKP2KITMAP4K4
SCHEMBL3443191 0.82 CKS1B (0.64) CKS1BSKP1SKP2KITMAP4K4
SCHEMBL2386105 0.82 GBA1 (0.54) CKS1BSKP1SKP2KITMAP4K4
SCHEMBL8515152 0.82 GPR119 (0.48) CKS1BSKP1SKP2KITMAP4K4
SCHEMBL27927181 0.82 HRH4 (0.61) CKS1BSKP1SKP2HRH4KIT
SCHEMBL3268748 0.81 CKS1B (0.56) CKS1BSKP1SKP2KITGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101981010-A Amide compound TAKEDA PHARMACEUTICAL 2011-02-23 CN disclosed
US-20100234389-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-16 US disclosed
EP-2199282-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2010-06-23 EP disclosed
US-20090163508-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234389-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA CKS1B 3175/4885SKP1 3469/4885SKP2 3535/4885
US-20090163508-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA CKS1B 3175/4885SKP1 3469/4885SKP2 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.